Form 4: LeMaitre Vascular CEO Acquires Additional Dividend Equivalent Rights
Insider Transaction Report
LeMaitre Vascular Inc.'s Chairman and CEO, George W. LeMaitre, acquired additional dividend equivalent rights on May 29, 2025, linked to his existing restricted stock and performance share unit awards.
Summary
- George W. LeMaitre, Chairman and CEO of LeMaitre Vascular Inc. (LMAT), reported the acquisition of dividend equivalent rights (DERs) on May 29, 2025.
- These DERs are associated with previously granted restricted stock unit (RSU) and performance share unit (PSU) awards.
- Each dividend equivalent right is the economic equivalent of one share of LeMaitre Vascular's common stock.
- The acquired DERs vest proportionately with their respective underlying RSU and PSU awards.
- The total number of DERs acquired across seven different grants on this date was 53.7859 units, with a transaction price of $0 per unit, as they represent accrued dividends.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as it reflects a routine compensation event that aligns the interests of the CEO with shareholders through equity-linked instruments, without indicating any negative operational or financial news.
Positives
- The acquisition of dividend equivalent rights by the Chairman and CEO indicates continued alignment of management's interests with those of shareholders, as these rights are tied to equity ownership.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This filing is a routine insider transaction report specific to LeMaitre Vascular Inc. and does not provide broader industry trends or competitive analysis. It reflects standard executive compensation practices within the medical device sector, where equity-linked incentives like RSUs and PSUs, along with their associated dividend equivalents, are common.
Related Party Transactions
- The reported transactions involve the acquisition of dividend equivalent rights by George W. LeMaitre, the Chairman and CEO, from LeMaitre Vascular Inc., which is a standard compensation-related transaction between an executive and the company.
Stakeholder Impact
- Shareholders: The acquisition of dividend equivalent rights by the CEO further aligns his financial interests with those of the shareholders, as the value of these rights is tied to the company's common stock performance.
Key Dates
| Date | Description |
|---|---|
| 12/02/2020 | Grant date of a restricted stock unit award to which dividend equivalent rights accrued. |
| 12/11/2021 | Grant date of a restricted stock unit award to which dividend equivalent rights accrued. |
| 12/12/2022 | Grant date of a restricted stock unit award and a Performance Share Unit (PSU) award to which dividend equivalent rights accrued. |
| 12/08/2023 | Grant date of a restricted stock unit award and a Performance Share Unit (PSU) award to which dividend equivalent rights accrued. |
| 12/06/2024 | Grant date of a restricted stock unit award to which dividend equivalent rights accrued. |
| 05/29/2025 | Date of transaction for the acquisition of dividend equivalent rights. |
| 06/02/2025 | Signature date of the reporting person's representative. |
Keywords
LeMaitre Vascular, LMAT, SEC Form 4, Insider Transaction, Dividend Equivalent Rights, Restricted Stock Units, Performance Share Units, Executive Compensation, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.